|
⚲
|
| Keyboard |
| Clarus Ventures III LLC | |
|---|---|
| Firm | Clarus Ventures LLC |
| Address | c/o Clarus Ventures, LLC 101 Main Street, Suite 1210 Cambridge, MA 02142 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Clarus Ventures LLC | |||||
| Clarus Lifesciences III LP | 021-211426 | Director | 234.2 M of 375.0 M |
24.8 M | |
| Clarus Ventures III GP LP | 021-225116 | Director | of 50.0 M |
||
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Gritstone bio Inc GRTS
Common Stock
|
2018-10-02 | Conversion | 2,234,112 | ||
|
Gritstone bio Inc GRTS
Series B Convertible Preferred Stock · derivative
|
2018-10-02 | Conversion | 668,896 | $0.00 | |
|
Gritstone bio Inc GRTS
Series A Convertible Preferred Stock · derivative
|
2018-10-02 | Conversion | 1,565,216 | $0.00 | |
|
Entasis Therapeutics Holdings Inc ETTX
Common Stock
|
2018-09-28 | Conversion | 323,341 | ||
|
Entasis Therapeutics Holdings Inc ETTX
Common Stock
|
2018-09-28 | Conversion | 412,583 | ||
|
Entasis Therapeutics Holdings Inc ETTX
Common Stock
|
2018-09-28 | Buy | 453,395 | $15.00 | 6,800,925 |
|
Entasis Therapeutics Holdings Inc ETTX
Common Stock
|
2018-09-28 | Conversion | 361,829 | ||
|
Entasis Therapeutics Holdings Inc ETTX
Series B Convertible Preferred Stock · derivative
|
2018-09-28 | Conversion | 7,500,000 | $0.00 | |
|
Entasis Therapeutics Holdings Inc ETTX
Series B-1 Tranche B Convertible Preferred Stock · derivative
|
2018-09-28 | Conversion | 8,552,024 | $0.00 | |
|
Entasis Therapeutics Holdings Inc ETTX
Series B-1 Tranche A Convertible Preferred Stock · derivative
|
2018-09-28 | Conversion | 6,702,213 | $0.00 | |
|
Gritstone bio Inc GRTS
Common Stock
|
2018-09-28 | Buy | 333,333 | $15.00 | 4,999,995 |
|
Forty Seven Inc FTSV
Series A-2 Preferred Stock · derivative
|
2018-07-02 | Conversion | 755,780 | ||
|
Forty Seven Inc FTSV
Common Stock
|
2018-07-02 | Buy | 200,000 | $16.00 | 3,200,000 |
|
Forty Seven Inc FTSV
Common Stock
|
2018-07-02 | Conversion | 1,922,682 | ||
|
Forty Seven Inc FTSV
Series B Preferred Stock · derivative
|
2018-07-02 | Conversion | 1,922,682 | ||
|
Forty Seven Inc FTSV
Series A-1 Preferred Stock · derivative
|
2018-07-02 | Conversion | 938,489 | ||
|
Forty Seven Inc FTSV
Common Stock
|
2018-07-02 | Conversion | 755,780 | ||
|
Forty Seven Inc FTSV
Common Stock
|
2018-07-02 | Conversion | 938,489 | ||
|
Tectonic Therapeutic Inc AVRO
Common Stock
|
2018-06-25 | Conversion | 2,283,434 | ||
|
Tectonic Therapeutic Inc AVRO
Series A Preferred Stock · derivative
|
2018-06-25 | Conversion | 9,435,150 | $0.00 | |
| showing 20 of 22 most recent transactions | |||||